Peresolimab, a humanized IgG1 monoclonal antibody treatment for rheumatoid arthritis, shows promising results in phase 2a trial
Patient input in a digital health application enhances the patient-reported outcomes in rheumatoid arthritis
ASCORE study reports improved abatacept retention and clinical response rates in patients who received early subcutaneous abatacept
